Skip to main content

Search results

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

Scroll down for content
An MSF staff member treats a patient at Rafah Indonesian Field Hospital in Gaza

In Gaza, staff are risking their lives to provide care

story Feb 27, 2024

story Mar 01, 2024

Small voices: The youngest victims of conflict in Ituri, DR Congo

A mother and child sit on a hospital bed at Salama Hospital in Bunia, DR Congo.

story Mar 04, 2024

Left to Drown: Distress calls unanswered in the Mediterranean

Comic illustration of a boat carrying people in the Mediterranean Sea.

story Feb 28, 2024

17 days in captivity along the US-Mexico border

A migrant woman's hands folded on her lap

story Mar 04, 2024

MSF UK board member killed during Israeli offensive in Khan Younis

Wreckage from Israeli airstrikes in Gaza in 2023.

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

146 results

Story | Sep 18, 2023

The long and winding road to affordable access to a key TB drug

Christophe Perrin, the MSF Access Campaign‘s TB advocacy pharmacist, discusses the need for secure affordable access to improved TB medicines.

Read More
An MSF doctor in India looks at an X-ray of a lung.

News | Sep 12, 2023

J&J and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools

Read More
A patient sits at a table in front of an MSF staff member for a free X-ray at an MSF tuberculosis (TB) screening sites in Manila.

Story | Jul 13, 2023

Johnson & Johnson deal falls short for people with TB

Johnson & Johnson must end its patent monopoly on bedaquiline so generic versions of this lifesaving drug can be widely produced.

Read More
A woman in a green headscarf and her young daughter are treated for drug resistant tuberculosis at MSF’s treatment center in Kandahar, Afghanistan.

News | Apr 26, 2023

J&J must stop blocking generic versions of lifesaving TB drug

J&J’s patent monopoly continues to keep bedaquiline out of reach.

Read More
Screening session for TB

News | Mar 23, 2023

MSF applauds rejection of J&J attempt to extend TB drug patent

The rejection of the salt form of bedaquiline is welcome news for people with drug-resistant tuberculosis.

Read More
Mirror of a woman wearing a surgical face mask in Mumbai, India.

News | Nov 08, 2022

MSF: Opportunity to increase access to newer, safer TB drugs is at risk

With newer TB drugs set to go off patent in 2023, drugmakers J&J, Otsuka, and TB Alliance must remove additional barriers that block more affordable versions from entering the market.

Read More
Chetan Kharatmol, DRTB patient from Chembur

News | Oct 18, 2021

EndTB clinical trial for multidrug-resistant tuberculosis concludes enrollment

Read More
A child sits between two people in surgical masks after completing TB treatment from MSF in Papua New Guinea.

News | Sep 03, 2021

MSF: Pediatric formulations of lifesaving TB medicines must be more widely affordable and available

Read More
An MSF doctor in India looks at an X-ray of a lung.

News | Jul 28, 2021

World Hepatitis Day: MSF launches partnership to tackle hepatitis C

Read More
Hepatitis C active case finding

Story | May 14, 2021

India: Responding to the COVID-19 crisis and other urgent needs

Read More
MSF responds to COVID-19 in Mumbai, India

Filters

Date range
For Donation Inquiries 
See donor options here
 
U.S. Media Inquiries 

Reach out to the press team
 
Non-U.S. Media Inquiries 

Contact the MSF office in your country/territory.
For Donation Inquiries 
See donor options here
 
U.S. Media Inquiries 

Reach out to the press team
 
Non-U.S. Media Inquiries 

Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.